EARLY DETECTION OF PANCREATIC DUCTAL ADENOCARCINOMA: CURRENT STRATEGIES AND EMERGING APPROACHES
Keywords:
Keywords: pancreatic cancer, early detection, biomarkers, surveillance, CA 19-9, liquid biopsyAbstract
Pancreatic ductal adenocarcinoma (PDAC) accounts for roughly 90% of pancreatic malignancies and remains one of the most lethal solid tumors, with a five-year survival rate of about 13%. Its poor prognosis is largely due to late diagnosis: fewer than one in five patients have surgically resectable disease at presentation, because early-stage tumors rarely cause specific symptoms.
Downloads
Published
2026-10-15
Issue
Section
Articles